WCN25-1553 EFFICACY AND SAFETY OF DAILY ORAL STEROID AND CYCLOPHOSPHAMIDE VERSUS CYCLICAL STEROID AND CYCLOPHOSPHAMIDE IN ADULT PATIENTS WITH MEMBRANOUS NEPHROPATHY :A RANDOMIZED CONTROLLED TRIAL

WCN25-1553 EFFICACY AND SAFETY OF DAILY ORAL STEROID AND CYCLOPHOSPHAMIDE VERSUS CYCLICAL STEROID AND CYCLOPHOSPHAMIDE IN ADULT PATIENTS WITH MEMBRANOUS NEPHROPATHY :A RANDOMIZED CONTROLLED TRIAL

Saved in:

Bibliographic Details
Main Authors:	Paromita Das, Anish Garg, Priti Meena, Sandip Kumar Panda, Suvendu Purkait
Format:	Article
Language:	English
Published:	Elsevier 2025-02-01
Series:	Kidney International Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024924024033
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

WCN25-2664 Low-dose versus Standard-dose cyclical Cyclophosphamide and Steroids in the treatment of Primary Membranous Nephropathy- a randomized controlled trial
by: Raja Ramachandran, et al.
Published: (2025-02-01)

WCN25-4267 EXPLORING INTEREST IN NEPHROLOGY AMONG GENERAL MEDICINE RESIDENTS: A NATION WIDE SURVEY
by: Anish Garg, et al.
Published: (2025-02-01)

WCN24-422 An Analysis of spectrum of Glomerular Diseases in Chronic Filariasis
by: Priti Meena, et al.
Published: (2024-04-01)

WCN25-1332 Evaluating the Role of Direct Oral Anticoagulants as a Safer and Effective Option for Thromboprophylaxis in Nephrotic Syndrome: A Prospective Observational Study
by: Priti Meena, et al.
Published: (2025-02-01)

Cyclophosphamide: An Overview
by: Aditya Kumar Bubna
Published: (2025-01-01)

Combination Therapy With Rituximab and Low-Dose Cyclophosphamide and Prednisone in Membranous Nephropathy
by: Coralien H. Vink, et al.
Published: (2024-12-01)

Efficacy of tacrolimus or cyclophosphamide combined with glucocorticoids in the treatment of idiopathic membranous nephropathy
by: MAO Wen-li, et al.
Published: (2018-01-01)

Meta-analysis of calcineurin inhibitor vs.cyclophosphamide in the treatment of idiopathic membranous nephropathy
by: XIE Guang-liang, et al.
Published: (2015-01-01)

WCN25-2290 EFFICACY OF INDUCTION TREATMENT WITH CYCLOPHOSPHAMIDE, RITUXIMAB AND THEIR COMBINATION IN PATIENTS WITH PAUCIIMMUNE VASCULITIS
by: Martín Benjamín Yamá Estrella, et al.
Published: (2025-02-01)

Cyclophosphamide-induced nail pigmentation: An uncommon presentation
by: Deepthi Konda, et al.
Published: (2025-01-01)

Intra Arterial Infusion of Cyclophosphamide in Oral Carcinoma
by: N. C. Misra, et al.
Published: (1970-12-01)

Safety of Cyclophosphamide Therapy in Autoimmune Rheumatic Diseases
by: Ramaswamy Subramanian, et al.
Published: (2019-01-01)

High Dose Cyclophosphamide Treatment for Autoimmune Disorders
by: Robert A. Brodsky
Published: (2002-01-01)

WCN24-889 BASILIXIMAB INDUCTION, STEROID USE AND RECURRENCE OF IGA NEPHROPATHY IN RENAL TRANSPLANT PATIENTS
by: Isabela Bertoni, et al.
Published: (2024-04-01)

Cyclophosphamide in highly aggressive Marburg-like multiple sclerosis
by: Tommaso Nicoletti, et al.
Published: (2021-10-01)

Cyclophosphamide in ovarian cancer subtypes: Time for a comeback
by: Ajit Venniyoor
Published: (2018-01-01)

Cyclophosphamide and mycophenolate mofetil as induction therapy in lupus nephritis
by: Božić-Majstorović Ljubinka, et al.
Published: (2024-01-01)

Infliximab for Idiopathic Deep Cutaneous Vasculitis Refractory to Cyclophosphamide
by: Marcelo Derbli Schafranski, et al.
Published: (2010-01-01)

Mycophenolate Mofetil and Steroid for Treatment of Patients With IgA Nephropathy
by: Jing Miao, et al.
Published: (2024-01-01)

Influence of Puncture Devices on the Accuracy of Cyclophosphamide Dosing for Chemotherapy Administration
by: Susana Carvalho, et al.
Published: (2025-06-01)

Potential Protective Effects of Antioxidants against Cyclophosphamide-Induced Nephrotoxicity
by: Muluken Altaye Ayza, et al.
Published: (2022-01-01)

Oral cyclophosphamide monotherapy in advanced resistant ocular cicatricial pemphigoid
by: Arash Maleki, et al.
Published: (2025-04-01)

Post-transplant cyclophosphamide-induced cardiotoxicity: A comprehensive review
by: Azin Alizadehasl, et al.
Published: (2024-12-01)

Combination Induction Immunosuppression With Rituximab, Cyclophosphamide, and Prednisone for Fibrillary Glomerulonephritis
by: Gabriel Sauvage, et al.
Published: (2025-03-01)

Effect of Cyclophosphamide (Endoxan-Asta) on Palate Development in Albino Rats
by: Shamer Singh, et al.
Published: (1972-07-01)

Rapidly progressive pleuro-parenchymal fibroelastosis secondary to cyclophosphamide chemotherapy
by: Maheema Bhaskar, et al.
Published: (2020-01-01)

A multicenter retrospective study on comparing the efficacy and safety of the therapy of intermittent cyclophosphamide and corticosteroids versus rituximab for primary membranous nephropathy
by: Yi Wang, et al.
Published: (2024-12-01)

WCN25-2494 SURPRISINGLY GOOD RESPONSE OF A SEVERE ANCA-NEGATIVE CRESCENTIC PAUCI-IMMUNE GLOMERULONEPHRITIS SUCCESSFULLY TREATED WITH CORTICOSTEROIDS, CYCLOPHOSPHAMIDE AND RITUXIMAB
by: Eleni Theodoropoulou, et al.
Published: (2025-02-01)

SURGERY COMPLICATIONS IN REPRODUCTIVE WOMEN, THEIR INTERACTION WITH CYCLIC CHANGES IN GONADOTROPHIC AND STEROID HORMONES
by: F. Z. Mirsaeva
Published: (2017-01-01)

Low-dose cyclophosphamide combined with chinese herbal medicine Shuli Fenxiao formula for the treatment of intermediate-to-high risk primary membranous nephropathy
by: Yiran Du, et al.
Published: (2025-04-01)

The influence of the plantain juice on the manifestations and outcome of acute cyclophosphamide intoxication in rats
by: T. V. Schäfer, et al.
Published: (2018-02-01)

Corrective effects of original bioflavonoid complex in the cyclophosphamide-induced immunity disorders
by: I. A. Goldina, et al.
Published: (2021-01-01)

The Effect of Quercetin on Ovary Functions in Rats with Cyclophosphamide Induced Ovary Damage
by: Ceren Yildiz Eren, et al.
Published: (2024-03-01)

Successful Treatment with Intravenous Cyclophosphamide for Refractory Adult-Onset Still’s Disease
by: Yoshika Tsuji, et al.
Published: (2015-01-01)

Splenectomy following rituximab and cyclophosphamide for severe autoimmune hemolytic anemia in pregnancy
by: Tao Wang, et al.
Published: (2025-12-01)

Atypical Bilateral Hyperpigmented Macules on the Lower Legs Possibly due to Cyclophosphamide
by: Jun Yamamoto, et al.
Published: (2024-12-01)

Effect of cyclophosphamide on regulation of heart contractions by means of sodium calcium exchanger
by: Tatyana A. Berezhnova, et al.
Published: (2025-02-01)

Protective effects and metabolomics analysis of dihydromyricetin on cyclophosphamide-induced hepatotoxicity in mice
by: Fei Teng, et al.
Published: (2025-12-01)

Vitamin A affects urothelial injury and regeneration in cyclophosphamide-induced cystitis
by: Dragar Brina, et al.
Published: (2024-01-01)

The Effects of Tempol on Cyclophosphamide-Induced Oxidative Stress in Rat Micturition Reflexes
by: Eric J. Gonzalez, et al.
Published: (2015-01-01)